Purple Biotech (PPBT) Interest & Investment Income (2014 - 2026)
Purple Biotech (PPBT) reported Interest & Investment Income of -$20000.0 for Q1 2026, up 62.96% year-over-year from -$12272.7 in Q1 2025, and up 62.96% on a QoQ basis from -$54000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Interest & Investment Income data on file, last reported at -$20000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 62.96% year-over-year to -$20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20000.0 (up 62.96% YoY) and the FY2025 annual result came in at $424000.0, down 51.15% from the prior year.
- Interest & Investment Income advanced to -$20000.0 in Q1 2026 per PPBT's latest filing, from -$54000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at -$20000.0 in Q1 2026 and bottomed at -$54000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | -79,000.00 |
| Sep 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -73,000.00 |
| Mar 31, 2025 | -54,000.00 |
| Dec 31, 2024 | -456,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -121,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | -708,000.00 |
| Jun 30, 2023 | -123,000.00 |
| Mar 31, 2023 | -278,000.00 |
| Dec 31, 2022 | -576,000.00 |
| Sep 30, 2022 | -248,000.00 |
| Jun 30, 2022 | -89,000.00 |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -56,000.00 |
| Sep 30, 2021 | -68,000.00 |
| Jun 30, 2021 | -78,000.00 |
| Mar 31, 2021 | -118,000.00 |
| Dec 31, 2020 | -170,000.00 |
| Dec 31, 2019 | -78,000.00 |
| Dec 31, 2018 | -69,000.00 |
| Dec 31, 2017 | -65,000.00 |
| Dec 31, 2016 | -138,000.00 |
| Dec 31, 2015 | 133,000.00 |
| Sep 30, 2015 | -291,000.00 |
| Dec 31, 2014 | 71,000.00 |
| Sep 30, 2014 | -70,000.00 |